Specialties
Reports that name this provider
- Stem Cell Legality in United States
- Subject to FDA enforcement action. U.S. District Judge granted summary judgment against this clinic for adulterating and misbranding a stem cell drug product made from a patient's adipose tissue. FDA raised initial concerns in 2017 warning letter for marketing stem cell products without FDA approval and significant deviations from current good manufacturing practice.